期刊
EXPERT REVIEW OF MEDICAL DEVICES
卷 12, 期 6, 页码 763-769出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/17434440.2015.1100071
关键词
interspinous spacer; lumbar spinal stenosis; Superion; laminectomy
资金
- Vertiflex Inc (San Clemente, Ca, USA)
- Vertiflex, Inc.
Objective: To compare the two-year clinical outcomes of a prospective, randomized controlled trial of an FDA-approved interspinous spacer with the compilation of published findings from 19 studies of decompressive laminectomy for the treatment of lumbar spinal stenosis. Methods: Back and leg pain, Oswestry disability index (ODI), and Zurich Claudication Questionnaire (ZCQ) values were compared between spacer- and laminectomy-treated patients preoperatively and at 12 and 24 months. Results: Percentage improvements between baseline and 24 months uniformly favored patients treated with the spacer for back pain (65% vs. 52%), leg pain (70% vs. 62%), ODI (51% vs. 47%) and ZCQ symptom severity (37% vs. 29%) and physical function (36% vs. 32%). Conclusion: Both treatments provide effective and durable symptom relief of claudicant symptoms. This stand-alone interspinous spacer offers the patient a minimally invasive option with less surgical risk.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据